Evaluation of Chronic Diseases Management Program (Prolanis)
- DOI
- 10.2991/ahsr.k.200612.053How to use a DOI?
- Keywords
- evaluation, prolanis, diabetes, hypertension, program
- Abstract
Diabetes and Hypertension are diseases that are on the ten most diseases list in Indonesia, thus increasing health costs. The government implemented chronic disease management program (prolanis) to prevent the disease. This study aims to analyze the implementation of prolanis conducted at the Sako Health Center in Palembang City. The method of this study approach is qualitative based on the CIPP evaluation model (Context, Input, Process, Product). Eleven informants were selected by a purposive method. Data collection by in-depth interviews, observations, document review. The validity test used the triangulation technique, method, and theory. The results show components of the input, and the process is less than optimal as human resource has not held BPJS health training for officers of the program, the workload of the high officials, the fund is claimed is not paid by BPJS, so there are activities that are not carried out. In the process, planning has no standard operational. Prolanis conducted not under existing guidelines, not optimal surveillance and monitoring. The product component, the expected target, has not yet been reached. It is expected that the public health center will carry out activities under existing guidelines.
- Copyright
- © 2020, the Authors. Published by Atlantis Press.
- Open Access
- This is an open access article distributed under the CC BY-NC license (http://creativecommons.org/licenses/by-nc/4.0/).
Cite this article
TY - CONF AU - D. Fitria Sari Firdaus AU - Haerawati Idris PY - 2020 DA - 2020/06/19 TI - Evaluation of Chronic Diseases Management Program (Prolanis) BT - Proceedings of the 2nd Sriwijaya International Conference of Public Health (SICPH 2019) PB - Atlantis Press SP - 376 EP - 383 SN - 2468-5739 UR - https://doi.org/10.2991/ahsr.k.200612.053 DO - 10.2991/ahsr.k.200612.053 ID - Firdaus2020 ER -